Functional characterisation of the osteoarthritis susceptibility locus at chromosome 6q14.1 marked by the polymorphism rs9350591
Open Access
- 7 September 2015
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 16 (1) , 1-11
Abstract
The arcOGEN genome-wide association study reported the rs9350591 C/T single nucleotide polymorphism (SNP) as marking a region on chromosome 6q14.1 that is associated with hip osteoarthritis (OA) in Europeans, with an odds ratio (OR) of 1.18 and a p-value of 2.42 × 10−9. rs9350591 is an intergenic SNP surrounded by seven genes within 1 Mb. Six of the genes are expressed in cartilage. We sought to characterise this signal to assess whether the association of rs9350591 with OA is mediated by modulating gene expression. Total RNA was extracted from hip or knee cartilage of 161 OA patients and from hip cartilage of 29 non-OA patients who had undergone hip replacements as a result of neck-of-femur (NOF) fractures. We used quantitative PCR (qPCR) to measure overall gene expression, and pyrosequencing to assess allelic expression of the genes. A mesenchymal stem cell (MSC) differentiation model was used to assess gene expression during chondrogenesis. We identified a significant decrease in the expression of SENP6 (p = 0.005) and MYO6 (p = 0.026) in OA hip cartilage relative to the non-OA hip control cartilage. However, we found no evidence for a correlation between gene expression and rs9350591 genotype for any of the six genes. In addition, we identified expression quantitative trait loci (eQTLs) operating on COL12A1, TMEM30A, SENP6 and MYO6, although these were not relevant to the OA associated signal. Finally, all genes were dynamically expressed during chondrogenesis. The regulation of gene expression at this locus is complex, highlighted by the down-regulation of SENP6 and MYO6 in OA hip cartilage and by eQTLs operating on four of the genes at the locus. However, modulation of gene expression in the end-stage OA cartilage that we have investigated is not the mechanism by which this association signal is operating. As implied by the dynamic patterns of gene expression throughout chondrogenesis, the association signal marked by rs9350591 could instead be exerting its effects during joint development.Keywords
Funding Information
- Arthritis Research UK (19953)
- Medical Research Council (CIMA)
This publication has 19 references indexed in Scilit:
- Allelic expression analysis of the osteoarthritis susceptibility locus that maps to chromosome 3p21 reveals cis-acting eQTLs at GNL3 and SPCS1BMC Medical Genetics, 2014
- Obesity-associated variants within FTO form long-range functional connections with IRX3Nature, 2014
- The genetics and functional analysis of primary osteoarthritis susceptibilityExpert Reviews in Molecular Medicine, 2013
- Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association studyThe Lancet, 2012
- Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissuesAnnals of the Rheumatic Diseases, 2012
- Genetics of osteoarthritisCurrent Opinion in Rheumatology, 2011
- Functional analysis of the osteoarthritis susceptibility–associated GDF5 regulatory polymorphismArthritis & Rheumatism, 2009
- Mapping complex disease traits with global gene expressionNature Reviews Genetics, 2009
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMapBioinformatics, 2008
- Pathogenesis and management of pain in osteoarthritisThe Lancet, 2005